CD8A and neoplasm: Meanwhile, IPI‐549 released in the tumor microenvironment could inhibit PI3Kγ in MDSCs to promote proliferation and activation of CD8+ T cells, decrease Tregs, reprogram the polarization of TAMs to M1‐like phenotype.